Search results for: Innovation Policy Prize
Filter search results
2015 OHE Annual Lecture: Regulation, Reimbursement, and Evidence on New Medical Technologies: Experiences and Future Directions in the United States
5 July 2015, 11:00pm
…Fellow and Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. His work focuses on strategies and policy reforms to improve health care, including…
International Drug Pricing Transparency
20 July 2020, 11:00pm
Join us on the 21st July between 15:00 – 16:30 BST as OHE experts discuss the economics, politics, and public policy of international drug pricing. Confidential net prices are currently…
Estimating US Savings from Biosimilars
13 July 2010
…Health. Since the seminar, the US has passed the Biologics Price Competition and Innovation Act of 2009, a subtitle of the Patient Protection and Affordable Care Act that was signed into law…
Competition in the NHS: ‘Payment by Results’
17 August 2010
…including: (1) the Commissioning for Quality and Innovation (CQUIN) payment framework, which makes a proportion of providers’ income conditional on quality and innovation and (2) payment-for-performance (P4P) schemes. Still uncertain…
OHE at iHEA: HTA in Emerging Markets, Personalised Medicine, EQ-5D mapping
6 August 2013
…economics. The discussions explored the challenges and potential responses raised by the shift in technology towards personalised medicine, which may entail higher costs and certainly will require innovation in pricing…
Assessing the Use of Multi-indication Medicines: A Review of Current Data Capabilities in the UK
31 March 2015
…the Health and Social Care Information Centre (HSCIC) in England on the Use of NICE appraised medicines in the NHS (now replaced by the Innovation Scorecard). As well as supporting…
OHE at AES 2016: Early Access Schemes, Equity Adjusted QALYs, Multi-indication Pricing and Formulary Development
2 August 2016
…patients with high unmet medical need and to incentivise innovation and R&D. Berdud and colleagues model existing early access and adaptive pathway policies for a real case study. They assess…
Presentations and Posters from ISPOR Europe 2016
24 November 2016
…the conference. This post contains their presentations and posters. Plenary session: Differential Pricing of Medicines in Europe: Implications for Access, Innovation, and Affordability. Moderator: Lou Garrison (University of Washington and OHE)….
Brittany Darrow
2 October 2024
…particularly interested in rare diseases and the impact of pricing and payment models on innovation and health system sustainability. She is a member of OHE’s economics of innovation (EoI) theme. …